A jury orders has asked Wyeth and Pharmacia & Upjohn Pfizer units to pay over $165 Million in damages to women who contacted cancer after long terms use of the drug manufacturer's Prempro hormone-replacement drug, combination of two hormone medicines actually, as has been confirmed by the lawyers representing the women.

Since 2006, juries have been meeting to settle lawsuits over the the ill-effects of the menopause medicines, and since then, Pfizer's Wyeth subsidiary has been slapped with as many as 5 "bad
-conduct" awards. But Pfizer officials have been quick to assert that some of these awards have either been reduced by judges or completely thrown out on the firm's appeal.

The latest claim in line has been the $28 Million awarded to Decatur, Illinois's Donna Kendall. "This is just the tip of the iceberg as Wyeth faces lawsuits from more than 10,000 additional women who also claim that Wyeth’s drugs gave them breast cancer”, lawyers for the women shared. The past verdicts have proved that "when jurors hear how Wyeth put huge profits over the safety of patients, they will react with a strong message of outrage".

Prempro was a very popular drug when it first came out, and an estimated 6 million women have, at one point of time or another, taken the hormone-replacement medicine to treat the common symptoms of menopause which include hot flashes, mood swings and night sweats. Until 1995, various women combined Premarin, Wyeth’s estrogen-based drug, with progestin-laden Provera, made by Upjohn.